MRC joins forces with GSK and the South African MRC to tackle NCDs in Africa

The MRC, the South African MRC, and GSK have teamed up under the Newton Fund in order to tackle non-communicable diseases (NCDs) in Africa.

The funders will collectively invest approximately £5m to support UK and South African academics to collaborate with scientists from GSK’s Africa NCD Open Lab in order to enhance our understanding of cancer, heart disease, diabetes and kidney disease in Africa.

The research programmes will see leading scientists coming together from across academia and industry, multiple scientific disciplines, and two countries, in order to tackle what is expected to become the most common cause of death in Africa by 2030. Read more.